Head and Neck Cancer and Immunotherapy

Thursday
October 7, 2021, 5:00 pm -
5:30 pm
New treatments to preserve quality of life

Watch On Demand

Session Description

Immunotherapy offers exciting new treatment options for patients with cancers of the mouth, throat, voice box, sinuses, nose, and salivary glands—especially those with HPV-positive cancers. Standard treatments have potentially devastating side effects for speaking, swallowing, and expression, so new options which preserve these functions are vital. Join Dr. Nabil Saba, director of the head and neck oncology program at Winship Cancer Institute at Emory University, in a Q&A discussion about the use of new checkpoint inhibitors and other immunotherapies in head and neck cancer. Ask him your questions about clinical trials, treatment regimens, side effects, and other topics.

Speaker(s)

Nabil F. Saba, M.D., FACP

Winship Cancer Institute at Emory University

Dr. Nabil Saba is a professor and vice chair for quality and safety at Emory University’s department of hematology and medical oncology and holds a joint appointment as a professor of otolaryngology at Emory University School of Medicine. He serves as the director of the head and neck oncology program and leads the head and neck working group at Winship Cancer Institute at Emory University. He is a recognized expert in head and neck cancer immunotherapy, focusing his work on translational research and the study and development of novel therapeutics in head and neck and esophageal cancer. Dr. Saba leads several clinical trials with a focus on biomarker endpoints and has received NIH funding to examine novel genomic approaches for diagnosing HPV positive oropharyngeal cancers. He has chaired the Head and Neck Cancer NCI Steering Committee’s Rare Tumors Task Forces. Dr. Saba is an appointed member of the ASCO Clinical Guidelines Committee as well as the ASCO Head and Neck Guideline Advisory Group.

On-Demand Now Available

We are excited to announce that videos from our 2021 Cancer Research Institute (CRI) Virtual Immunotherapy Patient Summit are now available to view on demand.

The on-demand videos can be found on each session page from the agenda.